EUVIMEDEUVIMED entdecken
Crossref

To Evaluate Effectiveness of Ferric Carboxymaltose in Treating Moderate Iron Deficiency Anemia in Pediatric Patients an Observational Study

Gaurav Mathur, Pankaj Kumar Singhal, Kavya R, Monika Dhakad

International Journal of Science and Research (IJSR) · 06.07.2026 · 354-360

DOI: 10.21275/sr26704160308 ↗

Kurz gefasst

Fachartikel in der Zeitschrift International Journal of Science and Research (IJSR), erschienen am 06.07.2026. Verfasst von Gaurav Mathur und 3 weiteren Autor:innen.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Iron deficiency anemia (IDA) is a major public health concern in pediatric populations, particularly in developing countries such as India. Oral iron therapy is limited by poor compliance and gastrointestinal side effects. Intravenous ferric carboxymaltose (FCM) offers a potential alternative for rapid correction of anemia.

Aim

To evaluate the effectiveness and safety of intravenous ferric carboxymaltose in children with moderate iron deficiency anemia.

Methods

This study was conducted in 93 pediatric patients aged 1-18 years with moderate iron deficiency anemia. Baseline hemoglobin (Hb), mean corpuscular volume (MCV), and serum ferritin were assessed. Quantitative C-reactive protein (Q-CRP) and stool occult blood tests were performed to exclude inflammatory states and blood loss. Mentzer index was used to exclude thalassemia. All patients received a single dose of intravenous ferric carboxymaltose (15 mg/kg). Hemoglobin levels were reassessed after 21 days. Statistical analysis was performed using paired t-test.

Results

The mean baseline hemoglobin was 8.02 ± 0.82 g/dL, which increased to 9.52 ± 1.08 g/dL after 21 days, with a mean rise of 1.50 ± 1.02 g/dL (p 0.05). Adverse effects were minimal, occurring in 2.15% of patients.

Conclusion

Intravenous ferric carboxymaltose appears to be a safe and effective option for short-term hematological improvement in children with moderate iron deficiency anemia. Further controlled studies with longer follow-up are warranted to confirm these findings.

Zitieren

APA

Mathur, G., Singhal, P. K., R, K., & Dhakad, M. (2026). To Evaluate Effectiveness of Ferric Carboxymaltose in Treating Moderate Iron Deficiency Anemia in Pediatric Patients an Observational Study. International Journal of Science and Research (IJSR), 354-360. https://doi.org/10.21275/sr26704160308

Vancouver

Mathur G, Singhal PK, R K, Dhakad M. To Evaluate Effectiveness of Ferric Carboxymaltose in Treating Moderate Iron Deficiency Anemia in Pediatric Patients an Observational Study. International Journal of Science and Research (IJSR). 2026:354-360. doi:10.21275/sr26704160308

BibTeX
@article{Mathur2026,
  author = {Mathur, Gaurav and Singhal, Pankaj Kumar and R, Kavya and Dhakad, Monika},
  title = {To Evaluate Effectiveness of Ferric Carboxymaltose in Treating Moderate Iron Deficiency Anemia in Pediatric Patients an Observational Study},
  journal = {International Journal of Science and Research (IJSR)},
  year = {2026},
  pages = {354--360},
  doi = {10.21275/sr26704160308}
}
Kostenlos starten →